Attorney Jonathan Orent, who also represents numerous Plaintiffs, tried the case.
The trial initially began on July 28, and jurors heard closing arguments on August 23. Late last week jurors indicated a potential deadlock, but they continued their deliberations after receiving a charge to continue deliberating from Associate Justice Richard A. Licht.
Trevino sued Davol Inc., a division of medical device company C.R. Bard Inc. after receiving the Ventralex brand mesh to treat a hernia that developed after surgery for an abdominal injury. His case was closely watched by both plaintiff and defense lawyers due to being the first in the country to go to trial in state court involving hernia mesh implants, following only a small number of trials involving hernia mesh implants in federal court.
The full trial was webcast and recorded gavel-to-gavel by CVN, and is available for viewing with a subscription to CVN’s online video library which also includes multiple trials involving transvaginal mesh implants.
Trevino’s claimed Bard manufactured the Ventralex patch with a type of plastic resin that causes an inflammatory reaction in human tissue, and that the patch “buckled” inside Trevino’s abdomen and had to be removed in a subsequent surgery. Plaintiffs in the many hernia mesh lawsuits pending throughout the country claim the devices left them beleaguered with side effects ranging from chronic pain to infections to nerve damage
Bard argued during trial that Trevino’s complex medical history and previous abdominal injury caused his alleged injuries, and that patches like the Ventralex are approved by federal regulators, remain on the market currently, and successfully treat thousands of patients every year without complications.
Thousand of our hernia mesh lawsuits remain pending in state court in Rhode Island, where Bard has its headquarters, and also in federal multi-district litigation consolidated in federal court in the Southern District of Ohio.